{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:00:11Z","timestamp":1789646411186,"version":"4.0.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2015,10,27]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              There has been an increasing interest in use of mineralocorticoid receptor antagonists (\n              <jats:styled-content style=\"fixed-case\">MRA<\/jats:styled-content>\n              s) in patients with heart failure with preserved ejection fraction (\n              <jats:styled-content style=\"fixed-case\">HFPEF<\/jats:styled-content>\n              ). However, a comprehensive evaluation of\n              <jats:styled-content style=\"fixed-case\">MRA<\/jats:styled-content>\n              effects on left ventricular (\n              <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content>\n              ) structure and function in these patients is lacking. In this meta\u2010analysis, we evaluated the effects of\n              <jats:styled-content style=\"fixed-case\">MRA<\/jats:styled-content>\n              s on\n              <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content>\n              structure and function among patients with diastolic dysfunction or\n              <jats:styled-content style=\"fixed-case\">HFPEF<\/jats:styled-content>\n              .\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods &amp; Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Randomized, controlled clinical trials evaluating the efficacy of\n              <jats:styled-content style=\"fixed-case\">MRA<\/jats:styled-content>\n              s in patients with diastolic dysfunction or\n              <jats:styled-content style=\"fixed-case\">HFPEF<\/jats:styled-content>\n              were included. The primary outcome was change in E\/e\u2019, a specific measure of diastolic function. Secondary outcomes included changes in other measures of diastolic function,\n              <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content>\n              structure, surrogate markers for myocardial fibrosis (carboxy\u2010terminal peptide of procollagen type I [\n              <jats:styled-content style=\"fixed-case\">PICP<\/jats:styled-content>\n              ] and amino\u2010terminal peptide of pro\u2010collagen type\u2010\n              <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>\n              [\n              <jats:styled-content style=\"fixed-case\">PIIINP<\/jats:styled-content>\n              ]), blood pressure, and exercise tolerance. In the pooled analysis,\n              <jats:styled-content style=\"fixed-case\">MRA<\/jats:styled-content>\n              use was associated with significant reduction in E\/e\u2019 (weighted mean difference [\n              <jats:styled-content style=\"fixed-case\">WMD<\/jats:styled-content>\n              ] [95% confidence interval {\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              }]: \u22121.68 [\u22122.03 to \u22121.33];\n              <jats:italic>P<\/jats:italic>\n              &lt;0.0001) and deceleration time (\n              <jats:styled-content style=\"fixed-case\">WMD<\/jats:styled-content>\n              [95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              ]: \u221212.0\u00a0ms [\u221223.3 to \u22120.7];\n              <jats:italic>P<\/jats:italic>\n              =0.04) as compared with control, suggesting and improvement in diastolic function. Furthermore, blood pressure and levels of\n              <jats:styled-content style=\"fixed-case\">PIIINP<\/jats:styled-content>\n              and\n              <jats:styled-content style=\"fixed-case\">PICP<\/jats:styled-content>\n              were also significantly reduced with\n              <jats:styled-content style=\"fixed-case\">MRA<\/jats:styled-content>\n              therapy with no significant change in\n              <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content>\n              mass or dimensions.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              <jats:styled-content style=\"fixed-case\">MRA<\/jats:styled-content>\n              therapy in patients with asymptomatic diastolic dysfunction or\n              <jats:styled-content style=\"fixed-case\">HFPEF<\/jats:styled-content>\n              is associated with significant improvement in diastolic function and markers of cardiac fibrosis without a significant change in\n              <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content>\n              mass or dimensions.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.115.002137","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T20:08:11Z","timestamp":1444766891000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":59,"title":["Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta\u2010Analysis and Systematic Review"],"prefix":"10.1161","volume":"4","author":[{"given":"Ambarish","family":"Pandey","sequence":"first","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, TX, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Garg","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical Center, Minneapolis, MN, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Matulevicius","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, TX, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amil M.","family":"Shah","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital, Boston, MA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalaj","family":"Garg","sequence":"additional","affiliation":[{"name":"New York Medical Center, Valhalla, NY, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Drazner","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, TX, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpesh","family":"Amin","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, TX, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarett D.","family":"Berry","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, TX, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Marwick","sequence":"additional","affiliation":[{"name":"Menzies Research Institute, University of Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Marso","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, TX, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"de Lemos","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, TX, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharam J.","family":"Kumbhani","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, TX, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052256"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051530"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.02.003"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805450"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14285-7"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.10.057"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2013.09.006"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032566"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.114.001583"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.011031"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.659763"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1201"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1993.1066"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)01129-3"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009492"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/chf.12011"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/chf.12022"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.25.837"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960281008"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2011.08.014"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-303329"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000036399.80194.D8"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2011.04.007"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000138680.89536.A9"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.08.021"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.905"},{"key":"e_1_3_3_30_2","first-page":"567","article-title":"Effects of spironolactone in treatment of elderly hypertensive patients with diastolic heart failure","volume":"8","author":"Liu G","year":"2006","unstructured":"Liu G, Ji ZG, Liu KS. Effects of spironolactone in treatment of elderly hypertensive patients with diastolic heart failure. Chin J New Drugs Clin Remedies. 2006;8:567\u2013570.","journal-title":"Chin J New Drugs Clin Remedies"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2014.05.010"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313731"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013255"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq426"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr292"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.000074"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.661983"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.716647"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.09.032"},{"key":"e_1_3_3_43_2","first-page":"558","article-title":"Management of diastolic heart failure","volume":"17","author":"Kazik A","year":"2010","unstructured":"Kazik A, Wilczek K, Polonski L. Management of diastolic heart failure. Cardiol J. 2010;17:558\u2013565.","journal-title":"Cardiol J"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.12.044"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.115.002137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:14:20Z","timestamp":1715595260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.115.002137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10,27]]}},"alternative-id":["10.1161\/JAHA.115.002137"],"URL":"https:\/\/doi.org\/10.1161\/jaha.115.002137","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]},"assertion":[{"value":"2015-04-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-07-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-10-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e002137"}}